These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6163641)

  • 21. Production of monoclonal antibodies by hybridomas sensitized to sporozoites of Plasmodium berghei.
    Danforth HD; Campbell GH; Leef MF; Beaudoin RL
    J Parasitol; 1982 Dec; 68(6):1029-33. PubMed ID: 6129292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of mouse monoclonal antibodies against human HLA-A3 for use in microlymphocytotoxicity technique.
    Yari F; Sareh S; Sadri A; Sharifi Z; Najafi F
    Hum Antibodies; 2009; 18(3):119-22. PubMed ID: 19729806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of secondary in vitro antibody responses by the third component of complement.
    Hobbs MV; Feldbush TL; Needleman BW; Weiler JM
    J Immunol; 1982 Mar; 128(3):1470-5. PubMed ID: 6460062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunogenic and antigenic epitopes of immunoglobulins. II. Antigenic differences between secreted and membrane IgG demonstrated using monoclonal antibodies.
    Partridge LJ; Lowe J; Hardie DL; Ling NR; Jefferis R
    J Immunol; 1982 Jan; 128(1):1-6. PubMed ID: 6172470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of mouse complement by different classes of mouse antibody.
    Klaus GG; Pepys MB; Kitajima K; Askonas BA
    Immunology; 1979 Dec; 38(4):687-95. PubMed ID: 521057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.
    Hack CE; Paardekooper J; Smeenk RJ; Abbink J; Eerenberg AJ; Nuijens JH
    J Immunol; 1988 Sep; 141(5):1602-9. PubMed ID: 2457622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A myeloma hybrid producing antibody specific for an allotypic determinant on "IgD-like" molecules of the mouse.
    Pearson T; Galfrè G; Ziegler A; Milstein C
    Eur J Immunol; 1977 Oct; 7(10):684-90. PubMed ID: 73464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of hybridoma-produced antibodies directed against Eimeria tenella and E. mitis.
    Danforth HD
    J Parasitol; 1982 Jun; 68(3):392-7. PubMed ID: 6178813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Murine tumor cell lysis by antibody-dependent macrophage-mediated cytotoxicity using syngeneic monoclonal antibodies.
    Kawase I; Komuta K; Ogura T; Fujiwara H; Hamaoka T; Kishimoto S
    Cancer Res; 1985 Apr; 45(4):1663-8. PubMed ID: 3978634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody.
    McMichael AJ; Pilch JR; Galfré G; Mason DY; Fabre JW; Milstein C
    Eur J Immunol; 1979 Mar; 9(3):205-10. PubMed ID: 376318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies against the human epidermoid carcinoma A 431.
    Prat M; Bussolati G; Spinnato MR; Comoglio PM
    Cancer Detect Prev; 1985; 8(1-2):169-79. PubMed ID: 4064036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The failure to show a necessary role for C3 in the in vitro antibody response.
    Waldmann H; Lachmann PJ
    Eur J Immunol; 1975 Mar; 5(3):185-93. PubMed ID: 1086224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody (BA-1) reactive with cells of human B lymphocyte lineage.
    Abramson CS; Kersey JH; LeBien TW
    J Immunol; 1981 Jan; 126(1):83-8. PubMed ID: 6969748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and localization of human pancreatic tumor-associated antigens by monoclonal antibodies to RWP-1 and RWP-2 cells.
    Chin J; Miller F
    Cancer Res; 1985 Apr; 45(4):1723-9. PubMed ID: 3884143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonal antibody against mouse sperm blocks a specific event in the fertilization process.
    Saling PM; Raines LM; O'Rand MG
    J Exp Zool; 1983 Sep; 227(3):481-6. PubMed ID: 6358404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies.
    Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ
    J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human complement (C3b) receptors defined by a mouse monoclonal antibody.
    Gerdes J; Naiem M; Mason DY; Stein H
    Immunology; 1982 Apr; 45(4):645-53. PubMed ID: 7068171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo activity of affinity-purified helper factor from antigen-specific helper clone.
    Azar Y; Falek PR; Kagan J; Ben-Sasson SZ
    J Immunol; 1985 Mar; 134(3):1717-22. PubMed ID: 2578517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.
    Kuroki M; Kuroki M; Koga Y; Matsuoka Y
    J Immunol; 1984 Oct; 133(4):2090-7. PubMed ID: 6206151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.